Only 13 percent of women report adequate employer-sponsored menopause support
Nearly two-thirds of Canadian women aged 35 to 55 say menopause symptoms affect their job performance, yet only 13 percent report access to adequate employer-sponsored support.
GreenShield, Canada's only national non-profit health care and insurance organization, is expanding its Personalized Hormonal Health Program to bring coordinated care to more Canadians.
The expansion embeds the clinical services of Coral, a Quebec-founded hormonal health platform, within the GreenShield+ ecosystem.
GreenShield said the expansion responds to persistent gaps in a category it describes as under-recognized and underserved.
Those gaps are wide, the company's latest Health Outcomes Report found.
Nearly 40 percent of women do not know where to seek care, and one in three wait at least two years after first noticing symptoms before receiving effective treatment.
Three in four Canadian women experience disruptive menopausal symptoms.
For plan sponsors, the report frames the issue as a workforce cost.
Hormonal transitions drive absenteeism, reduced performance and career disruption, GreenShield said, casting the problem as a largely invisible source of workforce disruption that employers can address through integrated support.
GreenShield launched what it calls Canada's first Personalized Hormonal Health Program in 2025, a nurse-led model combining diagnostic testing, personalized care plans, virtual consultations and pharmacy services within a single experience.
Since launch, member enrollment has grown and interest has accelerated among plan sponsors seeking more preventative and coordinated approaches.
The program covers perimenopause, menopause, post-menopause, andropause and other hormonal concerns, noting that hormonal health also affects men, often with limited awareness and support.
"Hormonal health has long been overlooked despite its significant impact on health outcomes, well-being and workforce participation," said Zahid Salman, GreenShield's president and chief executive.
He said strong member engagement and growing employer interest are shaping how the insurer evolves its approach.
Early program data point to demand from women in particular.
Among people who requested information about the program within GreenShield+, 72 percent were women, according to the report.
After a nurse assessment, 85 percent of those experiencing menopausal symptoms were referred into a menopause stream, about 40 percent received health coaching, and roughly 25 percent opted for at-home pharmacy delivery once prescribed medication.
Coral's co-founder pointed to the toll of delayed care.
"Too many women spend years searching for answers while symptoms affect their health, confidence and careers," said Anna Chif, adding that the platform aims to support GreenShield's push to widen access.
GreenShield said the program's distinguishing feature is not any single hormonal health service but the connection of that expertise with benefits coverage, pharmacy, mental health support, telemedicine and care navigation through one integrated experience.
According to the company, that structure lets members move between care and coverage as their needs change, an approach it says enables earlier intervention and better outcomes than standalone services.
